Maher Hanoun

3.1k total citations · 2 hit papers
24 papers, 1.5k citations indexed

About

Maher Hanoun is a scholar working on Hematology, Genetics and Molecular Biology. According to data from OpenAlex, Maher Hanoun has authored 24 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Hematology, 11 papers in Genetics and 5 papers in Molecular Biology. Recurrent topics in Maher Hanoun's work include Acute Myeloid Leukemia Research (9 papers), Hematopoietic Stem Cell Transplantation (8 papers) and Chronic Lymphocytic Leukemia Research (5 papers). Maher Hanoun is often cited by papers focused on Acute Myeloid Leukemia Research (9 papers), Hematopoietic Stem Cell Transplantation (8 papers) and Chronic Lymphocytic Leukemia Research (5 papers). Maher Hanoun collaborates with scholars based in Germany, United States and Taiwan. Maher Hanoun's co-authors include Paul S. Frenette, Sandra Pinho, Toshihide Mizoguchi, Yuya Kunisaki, Julie Lacombe, Ulrich Dührsen, Ingmar Bruns, Anna Arnal Estape, Maria Maryanovich and Noriaki Ono and has published in prestigious journals such as Neuron, The Journal of Experimental Medicine and Blood.

In The Last Decade

Maher Hanoun

21 papers receiving 1.5k citations

Hit Papers

PDGFRα and CD51 mark human Nestin+ sphere-forming mesench... 2013 2026 2017 2021 2013 2014 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Maher Hanoun Germany 12 671 474 414 335 292 24 1.5k
Fumio Nakahara Japan 19 510 0.8× 251 0.5× 547 1.3× 532 1.6× 259 0.9× 50 1.7k
Aya Ludin Israel 10 549 0.8× 255 0.5× 417 1.0× 378 1.1× 180 0.6× 17 1.2k
Daniel Martín-Pérez Spain 11 474 0.7× 402 0.8× 440 1.1× 242 0.7× 173 0.6× 14 1.1k
Qiaozhi Wei United States 14 1.2k 1.8× 595 1.3× 662 1.6× 715 2.1× 339 1.2× 18 2.1k
Joan Isern Spain 20 606 0.9× 604 1.3× 873 2.1× 355 1.1× 192 0.7× 31 2.0k
Lara Rossi Italy 18 382 0.6× 222 0.5× 446 1.1× 309 0.9× 143 0.5× 23 1.1k
Cédric Ghevaert United Kingdom 23 1.1k 1.7× 523 1.1× 610 1.5× 258 0.8× 132 0.5× 50 1.8k
Asaf Spiegel Israel 14 889 1.3× 553 1.2× 863 2.1× 1.1k 3.2× 1.2k 4.0× 16 2.8k
Hannah Briemberg Canada 15 528 0.8× 289 0.6× 626 1.5× 183 0.5× 458 1.6× 32 1.7k
Dianne Mitchell United States 17 256 0.4× 252 0.5× 814 2.0× 87 0.3× 192 0.7× 28 1.4k

Countries citing papers authored by Maher Hanoun

Since Specialization
Citations

This map shows the geographic impact of Maher Hanoun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maher Hanoun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maher Hanoun more than expected).

Fields of papers citing papers by Maher Hanoun

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maher Hanoun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maher Hanoun. The network helps show where Maher Hanoun may publish in the future.

Co-authorship network of co-authors of Maher Hanoun

This figure shows the co-authorship network connecting the top 25 collaborators of Maher Hanoun. A scholar is included among the top collaborators of Maher Hanoun based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maher Hanoun. Maher Hanoun is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Röllig, Christoph, Christoph Schliemann, Leo Ruhnke, et al.. (2024). Gemtuzumab ozogamicin plus midostaurin in combination with standard ‘7 + 3’ induction therapy in newly diagnosed AML: Results from the SAL‐MODULE phase I study. British Journal of Haematology. 204(6). 2254–2258. 3 indexed citations
2.
Eckardt, Jan‐Niklas, Christoph Röllig, Uwe Platzbecker, et al.. (2024). Mimicking clinical trials with synthetic acute myeloid leukemia patients using generative artificial intelligence. npj Digital Medicine. 7(1). 76–76. 26 indexed citations
3.
Röllig, Christoph, Christoph Schliemann, Jan‐Henrik Mikesch, et al.. (2021). Gemtuzumab Ozogamicin Plus Midostaurin in Combination with Standard Intensive Induction Therapy in Newly Diagnosed AML: Results from a Phase-I Study. Blood. 138(Supplement 1). 2324–2324. 6 indexed citations
4.
Mülling, Nils, et al.. (2021). Factor IX p.A37V mutation causes severe bleeding in a patient with phenprocoumon therapy. European journal of medical research. 26(1). 63–63.
5.
Chen, Yiyang, Michael Möllmann, Lin Yuan, et al.. (2021). Targeting CD38 in acute myeloid leukemia interferes with leukemia trafficking and induces phagocytosis. Scientific Reports. 11(1). 22062–22062. 15 indexed citations
6.
Schmid, Kurt Werner, Bernd Giebel, Ludger Klein‐Hitpaß, et al.. (2020). Acute myeloid leukemia–induced remodeling of the human bone marrow niche predicts clinical outcome. Blood Advances. 4(20). 5257–5268. 26 indexed citations
7.
Möllmann, Michael, et al.. (2020). Inflammation-driven activation of JAK/STAT signaling reversibly accelerates acute myeloid leukemia in vitro. Blood Advances. 4(13). 3000–3010. 36 indexed citations
8.
Hanoun, Maher, Anna Arnal Estape, Maria Maryanovich, et al.. (2019). Nestin+NG2+ Cells Form a Reserve Stem Cell Population in the Mouse Prostate. Stem Cell Reports. 12(6). 1201–1211. 9 indexed citations
9.
Hanoun, Christine, Andreas Hüttmann, Stefan Müller, et al.. (2019). Dynamic risk assessment based on positron emission tomography scanning in diffuse large B-cell lymphoma: Post-hoc analysis from the PETAL trial. European Journal of Cancer. 124. 25–36. 64 indexed citations
10.
Noppeney, Richard, et al.. (2019). Etoposide Combined with FLAG Salvage Therapy Is Effective in Multiple Relapsed/Refractory Acute Myeloid leukemia. Acta Haematologica. 143(5). 438–445. 4 indexed citations
11.
Hanoun, Christine, Andreas Hüttmann, Stefan Müller, et al.. (2019). Supporting data for positron emission tomography-based risk modelling using a fixed-instead of a relative thresholding method for total metabolic tumor volume determination. Data in Brief. 28. 104976–104976. 2 indexed citations
12.
Noppeney, Richard, et al.. (2018). FLAG salvage therapy combined with idarubicin in relapsed/refractory acute myeloid leukemia. Leukemia & lymphoma. 60(4). 1014–1022. 21 indexed citations
13.
Hanoun, Maher & Ulrich Dührsen. (2017). The Maze of Diagnosing Hemophagocytic Lymphohistiocytosis: Single-Center Experience of a Series of 6 Clinical Cases. Oncology. 92(3). 173–178. 3 indexed citations
14.
Hanoun, Maher, Maria Maryanovich, Anna Arnal Estape, & Paul S. Frenette. (2015). Neural Regulation of Hematopoiesis, Inflammation, and Cancer. Neuron. 86(2). 360–373. 196 indexed citations
15.
Li, Yu, et al.. (2015). Functional abnormalities and changes in gene expression in fibroblasts and macrophages from the bone marrow of patients with acute myeloid leukemia. International Journal of Hematology. 102(3). 278–288. 6 indexed citations
16.
Mizoguchi, Toshihide, Sandra Pinho, Jalal Ahmed, et al.. (2014). Osterix Marks Distinct Waves of Primitive and Definitive Stromal Progenitors during Bone Marrow Development. Developmental Cell. 29(3). 340–349. 338 indexed citations breakdown →
17.
Hanoun, Maher, Dachuan Zhang, Toshihide Mizoguchi, et al.. (2014). Acute Myelogenous Leukemia-Induced Sympathetic Neuropathy Promotes Malignancy in an Altered Hematopoietic Stem Cell Niche. Cell stem cell. 15(3). 365–375. 276 indexed citations
18.
Hanoun, Maher, Lewin Eisele, Masako Suzuki, et al.. (2012). Epigenetic Silencing of the Circadian Clock Gene CRY1 is Associated with an Indolent Clinical Course in Chronic Lymphocytic Leukemia. PLoS ONE. 7(3). e34347–e34347. 41 indexed citations
19.
Aydin, Semra, Florian Grabellus, Lewin Eisele, et al.. (2011). Investigating the role of CD38 and functionally related molecular risk factors in the CLL NOD/SCID xenograft model. European Journal Of Haematology. 87(1). 10–19. 21 indexed citations
20.
Hanoun, Maher, et al.. (2011). Acral ischemia as a presenting manifestation of essential thrombocythemia. International Journal of Hematology. 94(3). 219–220.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026